160 related articles for article (PubMed ID: 12465385)
1. [Mass screening of gastric cancer--limits and prospects].
Yamaki G; Higashi K
Gan To Kagaku Ryoho; 2002 Nov; 29(11):1883-7. PubMed ID: 12465385
[TBL] [Abstract][Full Text] [Related]
2. The usefulness of gastric mass screening using serum pepsinogen levels compared with photofluorography.
Yoshihara M; Sumii K; Haruma K; Kiyohira K; Hattori N; Tanaka S; Kajiyama G; Shigenobu T
Hiroshima J Med Sci; 1997 Jun; 46(2):81-6. PubMed ID: 9232936
[TBL] [Abstract][Full Text] [Related]
3. [Pepsinogen].
Miki K
Nihon Rinsho; 1995 May; 53(5):1198-202. PubMed ID: 7602778
[TBL] [Abstract][Full Text] [Related]
4. The impact of mass screening on gastric cancer mortality in Japan.
Kawai K; Watanabe Y
Gastrointest Endosc; 1998 Mar; 47(3):320-3. PubMed ID: 9540897
[No Abstract] [Full Text] [Related]
5. Effectiveness of gastric mass screening in Japan.
Hisamichi S; Sugawara N; Fukao A
Cancer Detect Prev; 1988; 11(3-6):323-9. PubMed ID: 3390854
[TBL] [Abstract][Full Text] [Related]
6. Decreased death from gastric cancer by endoscopic screening: association with a population-based cancer registry.
Hosokawa O; Miyanaga T; Kaizaki Y; Hattori M; Dohden K; Ohta K; Itou Y; Aoyagi H
Scand J Gastroenterol; 2008; 43(9):1112-5. PubMed ID: 18609154
[TBL] [Abstract][Full Text] [Related]
7. Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males.
Yanaoka K; Oka M; Mukoubayashi C; Yoshimura N; Enomoto S; Iguchi M; Magari H; Utsunomiya H; Tamai H; Arii K; Ohata H; Fujishiro M; Takeshita T; Mohara O; Ichinose M
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):838-45. PubMed ID: 18398025
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of mass screening for gastric carcinoma.
Kunisaki C; Ishino J; Nakajima S; Motohashi H; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono HA; Shimada H
Ann Surg Oncol; 2006 Feb; 13(2):221-8. PubMed ID: 16411143
[TBL] [Abstract][Full Text] [Related]
9. Long-term results of gastric cancer screening using the serum pepsinogen test method among an asymptomatic middle-aged Japanese population.
Miki K; Fujishiro M; Kodashima S; Yahagi N
Dig Endosc; 2009 Apr; 21(2):78-81. PubMed ID: 19691778
[TBL] [Abstract][Full Text] [Related]
10. [Current issues and future prospects of gastric mass survey].
Hisamichi S
Gan No Rinsho; 1984 May; 30(6 Suppl):581-7. PubMed ID: 6748229
[TBL] [Abstract][Full Text] [Related]
11. Lower risk of death from gastric cancer among participants of gastric cancer screening in Japan: a population-based cohort study.
Miyamoto A; Kuriyama S; Nishino Y; Tsubono Y; Nakaya N; Ohmori K; Kurashima K; Shibuya D; Tsuji I
Prev Med; 2007 Jan; 44(1):12-9. PubMed ID: 16956654
[TBL] [Abstract][Full Text] [Related]
12. [Effectiveness and feasibility of a strategy for increasing participation in the Japanese Stomach Cancer Examination programs by incorporating serum pepsinogen tests].
Kurosawa M; Kikuchi S; Arisue T; Fukao A
Nihon Koshu Eisei Zasshi; 1998 Apr; 45(4):352-60. PubMed ID: 9691665
[TBL] [Abstract][Full Text] [Related]
13. Validity of serum pepsinogen levels and quininium resin test combined for gastric cancer screening.
Kim JR; Lee K; Jung WT; Lee OJ; Kim TH; Kim HJ; Lee JS; Passaro DJ
Cancer Detect Prev; 2005; 29(6):570-5. PubMed ID: 16289505
[TBL] [Abstract][Full Text] [Related]
14. Screening for gastric cancer in Korea: population-based preferences for endoscopy versus upper gastrointestinal series.
Choi KS; Kwak MS; Lee HY; Jun JK; Hahm MI; Park EC
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1390-8. PubMed ID: 19383892
[TBL] [Abstract][Full Text] [Related]
15. [Detection of early esophageal and gastric cancers by mass screening].
Mitsunaga N; Tsubouchi H
Nihon Rinsho; 1996 May; 54(5):1415-20. PubMed ID: 8965377
[TBL] [Abstract][Full Text] [Related]
16. Mortality from gastric cancer in patients followed with upper gastrointestinal endoscopy.
Ogura M; Hikiba Y; Maeda S; Matsumura M; Okano K; Sassa R; Yoshida H; Kawabe T; Omata M
Scand J Gastroenterol; 2008; 43(5):574-80. PubMed ID: 18415750
[TBL] [Abstract][Full Text] [Related]
17. A minute gastric cancer detected by a new screening method using serum pepsinogen I and II.
Yahagi N; Miki K; Ichinose M; Kakei N; Matsushima M; Kido M; Shimizu Y; Ishihama S; Tsukada S; Kurokawa K
Adv Exp Med Biol; 1995; 362():145-8. PubMed ID: 8540313
[No Abstract] [Full Text] [Related]
18. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
Cao Q; Ran ZH; Xiao SD
J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
[TBL] [Abstract][Full Text] [Related]
19. [Problems associated with mass-screening system for gastric cancer in Japan].
Kikuchi S; Inaba Y
Nihon Koshu Eisei Zasshi; 1992 Jul; 39(7):380-6. PubMed ID: 1504332
[TBL] [Abstract][Full Text] [Related]
20. Reduction in gastric cancer mortality by screening based on serum pepsinogen concentration: a case-control study.
Yoshihara M; Hiyama T; Yoshida S; Ito M; Tanaka S; Watanabe Y; Haruma K
Scand J Gastroenterol; 2007 Jun; 42(6):760-4. PubMed ID: 17505999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
